#TheFutureIsYours Prescribing a healthier future for Europeans
EU SURVEY: The impact of the COVID-19 pandemic on non-communicable and chronic patients' therapeutic adherence across Europe.
After nearly two years it is still urgent to better address the consequences of the Covid-19 pandemic. Evidence collected during the crisis show that the Covid-19 has had a significant impact also on non-communicable diseases (NCDs). Indeed, oncological and chronic patients have been left almost alone for months. In line with its long-term commitment on therapeutic adherence, Cittadinanzattiva - Active Citizenship Network are launching an EU Survey with the aim to better contribute starting from citizens' and patients' perspective on understanding the impact of the COVID-19 pandemic on non-communicable and chronic patients' therapeutic adherence. The aim is to enlighten experienced difficulties, unmet needs and new expectations in terms of continuity of care, access and adherence to therapies from the patient associations' & advocacy groups' perspective towards more resilient healthcare systems. The questionnaire - realized in the framework of the EU project "Therapeutic adherence during the COVID-19 pandemic across Europe: impact, experiences and perspectives from PAGs & relevant stakeholders" - is directed to patient associations & advocacy groups with the objective to collect information on the impact of Covid-19 pandemic on the adherence to therapies and the access to healthcare systems in their context, based on their experiences and on the information they received, without referring to specific pathologies and starting from patients affected by chronic and non-communicable diseases. Please note that the survey is anonymous and it takes no more than a few minutes to be filled out. To know more about this project, visit: http://www.activecitizenship.net/patients-rights/projects/397-therapeutic-adherence-during-the-covid-19-pandemic-across-europe-impact-experiences-and-perspectives-from-pags-relevant-stakeholders.html
15:00 - 23:55
Version number 3 (of 3) see other versions
Report inappropriate content
Is this content inappropriate?